|
|||||
|
|||||
Hello Nature readers, |
|||||
|
|||||
![]() |
|||||
Anti-CD40 monoclonal antibodies with different grip strengths. (Xiaojie Yu et al./Nature) | |||||
A looser grip makes some antibodies strongerImmunomodulatory antibodies can be more effective at stimulating the immune system to fight cancer if they bind less tightly. This is a surprising finding because natural antibodies that neutralize infections always have a strong grip on pathogens. Researchers investigated three receptors that are often targeted by cancer immunotherapies and found that loosely binding antibodies were more effective at influencing the behaviour of immune cells. The finding overturns thinking that antibodies should always be engineered to have a tight grip on their targets. Reference: Nature paper (1 February) |
|||||
A new form of cell deathA never-before-seen type of cell death called ‘disulfidptosis’ could be exploited to kill resistant cancers. Researchers triggered this type of cell death by starving cancer cells of glucose, which led to a build-up of disulfide molecules that caused the cytoskeleton to collapse. There are several other forms of cell death, but apoptosis is the target of most cancer treatments. Reference: Nature Cell Biology paper (6 February) |
|||||
‘Where’ matters as much as ‘what’The way in which antigens are arranged on nanoparticles affects whether a cancer vaccine triggers an immune response or not. When two classes of antigens were planted on the same spherical nanoparticles, they produced a 30% increase in T-cell activation compared with a nanoparticle with one antigen. “For [cancer] vaccine efficacy, antigen placement may be as critical as antigen choice,” the researchers behind the study write. Reference: Nature Biomedical Engineering paper (30 January) |
|||||
Fewer mutations in children than adultsPaediatric tumours have a smaller number of mutations than adult cancers. A whole-genome analysis of 27 paediatric-cancer subtypes found that they contained fewer single-base substitutions and small insertions and deletions than did adult cancers. Understanding the mutational signatures of childhood cancer could help researchers to develop cancer biomarkers. Reference: Nature Cancer paper (26 January) |
|||||
|
|||||
Put down the baconEating lots of ultra-processed foods — such as junk food, fizzy drinks, frozen meals and packaged cold meats — increases your risk of dying from cancer. A UK study of more than 197,000 people showed that a 10% increase in consumption of ultra-processed foods led to a 2% increased risk of being diagnosed with cancer and a 6% increased risk of dying from cancer. Ultra-processed foods typically contain artificial flavours, salt, sweeteners, fat and preservatives to make them longer lasting, more affordable and tastier. These foods are often marketed as healthy — but they are far from it. Forbes | 7 min read (paywall)Reference: eClinicalMedicine paper (31 January) |
|||||
In the news
|
|||||
|
|||||
The nuclear-missile personnel with cancerThe US Congress is investigating a concerning number of cancer diagnoses among people who worked at nuclear-missile launch control centres over the past 50 years. Among the cases being investigated is that of Mark Holmes, a former air force officer who died of Hodgkin’s lymphoma in 2020, at the age of 37, after working as a ‘missileer’. “He was so healthy,” says his wife, Jenny Holmes. “He was fit. He exercised, ate healthily. He never had any concerns at all.” The Washington Post | 14 min read |
|||||
Quote of the week“Now that I know how powerful the knowledge is, and that there is support, I wish I hadn’t waited.”Despite her mother dying of breast cancer in her mid-30s, Hilary Osborne didn’t want the stress and worry that would accompany a positive test for BRCA, a harmful gene variant linked to the condition. She now regrets not having the information sooner. (The Guardian | 5 min read) |
|||||
|
|||||
|
|||||
|
|||||
|
|||||
You received this newsletter because you subscribed with the email address: felicity.nelson@frogsandstars.com Please add briefing@nature.com to your address book. Enjoying this newsletter? You can use this form to recommend it to a friend or colleague — thank you! Had enough? Unsubscribe from Nature Briefing: Cancer. Fancy a bit of a read? View our privacy policy. Forwarded by a friend? Get the Briefing straight to your inbox: subscribe for free. Get more from Nature: Register for free on nature.com to sign up for other newsletters specific to your field and email alerts from Nature Research journals. Nature | The Springer Nature Campus, 4 Crinan Street, London, N1 9XW, United Kingdom Nature Research, part of Springer Nature. |